Taking Your TKI / CML and Tyrosine Kinase Inhibitors / Chronic Myeloid Leukemia Treatment

0 Views

07/08/23

This video is about the importance of taking your TKI and adherence to TKI therapy.

0:00 Start
0:41 Why is Adherence Important?
1:26 Adherence Tips

Research Studies:
Ibrahim AR, Eliasson L, Apperley JF, et al. Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy. Blood. 2011 Apr 7;117(14):3733–3736.

Marin D, Bazeos A, Mahon FX, et al. Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2010 May 10;28(14):2381–2388.

#cml #tki #chronicmyeloidleukemia